Cargando…
Carbapenem-Resistant Enterobacteriaceae: A Retrospective Review of Presentation, Treatment, and Clinical Outcomes in a Tertiary Care Referral Hospital
Background: Carbapenem-resistant Enterobacteriaceae (CRE) is an emerging infectious threat with an increasing incidence locally and worldwide. It carries a high morbidity and mortality; focusing on this topic should be a priority in clinical research as local data are not widely available. The objec...
Autores principales: | Al Khamis, Mohammed, AlMusa, Zainab, Hashhoush, Mai, Alsaif, Narjis, Salam, Abdul, Atta, Manal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392368/ https://www.ncbi.nlm.nih.gov/pubmed/36004017 http://dx.doi.org/10.7759/cureus.27094 |
Ejemplares similares
-
Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
por: El-Mahallawy, Hadir A., et al.
Publicado: (2022) -
Prevalence of Carbapenem-Resistant Enterobacteriaceae in Western Saudi Arabia and Increasing Trends in the Antimicrobial Resistance of Enterobacteriaceae
por: Taha, Rbab, et al.
Publicado: (2023) -
Leifsonia Species Bacteremia in a Hemodialysis Patient: A Difficult-to-Identify Organism
por: Al-Sardi, Mais, et al.
Publicado: (2021) -
Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia
por: Zikri, Ahmed, et al.
Publicado: (2021) -
Clinical Outcomes in Carbapenem-Resistant Enterobacteriaceae Infections Treated With Ceftazidime-Avibactam: A Single-Center Observational Study
por: Rathish, Balram, et al.
Publicado: (2021)